Dopamine (1) is a key neurotransmitter whose impact on pharmacological processes mediated by family of dopamine receptors designated D1, D2, D3, D4, and D5. Various diseases conditions such as schizophrenia, drug abuse, depression, restless leg syndrome, Parkinson’s disease (PD), inflammatory have been linked to aberrant D3 activity. Herein, we report series novel ligands with improved solubili...